<DOC>
	<DOCNO>NCT00693693</DOCNO>
	<brief_summary>The purpose research study well understand adherence Locoid people use treat atopic dermatitis .</brief_summary>
	<brief_title>Adherence Topical Hydrocortisone 17-butyrate 0.1 % ( Locoid® ) Using Different Vehicles Adults With Atopic Dermatitis</brief_title>
	<detailed_description>An investigator-blinded prospective study subject mild moderate atopic dermatitis ( &gt; 5 % Body Surface area 2 3 Investigator Global Assessment ( IGA ) scale ) . The drug use within FDA-approved labeling . Approximately 30 male female adult age ≥18 year enrol informed consent . Subjects ask participate help u determine well Locoid® work atopic dermatitis . Adherence measure MEMs cap .</detailed_description>
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<mesh_term>Hydrocortisone 17-butyrate 21-propionate</mesh_term>
	<mesh_term>Cortisol succinate</mesh_term>
	<mesh_term>Hydrocortisone acetate</mesh_term>
	<mesh_term>Hydrocortisone</mesh_term>
	<mesh_term>Butyric Acid</mesh_term>
	<mesh_term>Hydrocortisone-17-butyrate</mesh_term>
	<criteria>Male female ≥ 18 year age . Subjects must diagnosis mild moderate atopic dermatitis use IGA criterion . ( 2 3 severity scale ) Subjects must &gt; 5 % TBSA &lt; 30 % enrol . Women child bear potential allow participate study , subject require use least one form birth control . Known allergy sensitivity topical Locoid® cream , ointment lipocream subject . Inability complete studyrelated visit . Introduction prescription medication , topical systemic , atopic dermatitis participate study . Requiring &gt; 130 gm cream 2 week period . Having facial groin involvement disease . Pregnant woman woman breast feeding exclude . Women child bear potential allow participate study , subject require use least one form birth control .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>